Atara Biotherapeutics Inc
F:AT2
Atara Biotherapeutics Inc
F:AT2
Price:
9.25
EUR
Market Cap:
€1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
A
|
Agnico Eagle Mines Ltd
XMUN:AE9
|
CA |
Shareholder Yield
Current shareholder yield for 
AT2 is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
AT2 Price
Atara Biotherapeutics Inc
Atara Biotherapeutics Inc
Annual Price Range
9.25
52w Low
N/A
52w High
N/A
Price Metrics
| Average Annual Return | -37.09% |
| Standard Deviation of Annual Returns | 57.67% |
| Max Drawdown | -99% |
Shares Statistics
| Market Capitalization | 105m EUR |
| Shares Outstanding | 120 416 000 |
| Percentage of Shares Shorted |
N/A
|
AT2 Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
AT2's latest stock split occurred on Jun 20, 2024
The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.
Before the split, AT2 traded at 0.37 per share. Afterward, the share price was about 9.25.
The adjusted shares began trading on Jun 20, 2024. This was the only stock split in AT2's history.
Pre-Split Price
9.25
0.37
Post-Split Price
9.25
Before
After
